Rahaman Shaik

New Delhi, DL, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

The design and discovery of topoisomerase-II inhibitors as new cancer drugs: current strategies and future perspectives.

The design and discovery of topoisomerase-II inhibitors as new cancer drugs: current strategies and future perspectives.

Journal: Expert opinion on drug discovery

Published: May 26, 2026

Tubulin polymerization inhibitors in early clinical studies as cancer therapeutics.

Tubulin polymerization inhibitors in early clinical studies as cancer therapeutics.

Journal: Expert opinion on investigational drugs

Published: March 04, 2026

Comprehensive Review on How Repurposed Drugs Modulate Antitumor Immunity: Harnessing Damage-Associated Molecular Patterns.

Comprehensive Review on How Repurposed Drugs Modulate Antitumor Immunity: Harnessing Damage-Associated Molecular Patterns.

Journal: Cancer biotherapy & radiopharmaceuticals

Published: October 20, 2025

Effects of Cancer Therapies on Immunoglobulin Synthesis: A Review of Mechanisms, Clinical Implications, and Mitigation Strategies.

Effects of Cancer Therapies on Immunoglobulin Synthesis: A Review of Mechanisms, Clinical Implications, and Mitigation Strategies.

Journal: Cancer biotherapy & radiopharmaceuticals

Published: October 06, 2025

An Update on Alkylating Agents in Breast Cancer Therapy.

An Update on Alkylating Agents in Breast Cancer Therapy.

Journal: Cancer biotherapy & radiopharmaceuticals

Published: September 17, 2025

Decoding the tumor immune landscape: emerging TIL subsets as prognostic biomarkers and therapeutic targets.

Decoding the tumor immune landscape: emerging TIL subsets as prognostic biomarkers and therapeutic targets.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: September 10, 2025

Innovative immunotherapy approaches: harnessing synergy of dual checkpoint blockade in oncology.

Innovative immunotherapy approaches: harnessing synergy of dual checkpoint blockade in oncology.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: September 01, 2025

Advances in STING Pathway Modulation for Cancer and Immunotherapy: A Comprehensive Review of Preclinical and Clinical Studies (2020-2024).

Advances in STING Pathway Modulation for Cancer and Immunotherapy: A Comprehensive Review of Preclinical and Clinical Studies (2020-2024).

Journal: Cancer biotherapy & radiopharmaceuticals

Published: August 05, 2025

Immunotherapeutics in Combination with Chemotherapy in Clinical Trials.

Immunotherapeutics in Combination with Chemotherapy in Clinical Trials.

Journal: Reviews on recent clinical trials

Published: July 02, 2025

Nanotherapeutics to Overcome Chemotherapy Resistance in Ovarian Cancer.

Nanotherapeutics to Overcome Chemotherapy Resistance in Ovarian Cancer.

Journal: Pharmaceutical research

Published: June 12, 2025

Immunotherapeutics in Clinical Trials for Cervical Cancer.

Immunotherapeutics in Clinical Trials for Cervical Cancer.

Journal: Cancer biotherapy & radiopharmaceuticals

Published: April 23, 2025

Drug Repurposing in Oncology: A Strategic Pathway to Unlocking New Therapeutic Potential.

Drug Repurposing in Oncology: A Strategic Pathway to Unlocking New Therapeutic Potential.

Journal: Therapeutic innovation & regulatory science

Published: April 11, 2025

Showing 1-12 of 18

Last Updated: 09/26/2026